We are live on ! Find out more
GFM

GF Fund Management Portfolio holdings

AUM $5.98B
1-Year Est. Return 80.99%
This Fund
S&P 500
This Quarter Est. Return
+20.94%
1 Year Est. Return
+80.99%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.51B
AUM Growth
+$540M
Cap. Flow
-$18.6M
Cap. Flow %
-0.34%
Top 10 Hldgs %
46.25%
Holding
691
New
31
Increased
112
Reduced
426
Closed
60

Top Buys

Rank Stock Value
1
LITE icon
Lumentum
LITE
+$33.3M
2
BE icon
Bloom Energy
BE
+$30.1M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$25M
4
SNDK
Sandisk
SNDK
+$23.5M
5
NBIS
Nebius Group N.V.
NBIS
+$22.4M

Top Sells

Rank Stock Value
1
BTI icon
British American Tobacco
BTI
+$36.2M
2
CLS icon
Celestica
CLS
+$21.9M
3
WMT icon
Walmart Inc
WMT
+$21.5M
4
UNH icon
UnitedHealth
UNH
+$20.7M
5
YUMC icon
Yum China
YUMC
+$14.8M

Sector Composition

Rank Sector Weight
1 Technology 48.98%
2 Communication Services 15.81%
3 Consumer Discretionary 13.07%
4 Healthcare 6.06%
5 Consumer Staples 4.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZYME icon
451
Zymeworks
ZYME
$1.67B
$27.6K ﹤0.01%
1,617
-146
-8% -$2.09K
GMAB icon
452
Genmab
GMAB
$17.6B
$27.6K ﹤0.01%
900
-173
-16% -$4.22K
DRH icon
453
Diamondrock Hospitality Co
DRH
$2.64B
$27.6K ﹤0.01%
3,464
-219
-6% -$1.77K
GNL icon
454
Global Net Lease
GNL
$1.86B
$27.5K ﹤0.01%
3,377
-52
-2% -$397
JBGS
455
JBG SMITH
JBGS
$820M
$26.9K ﹤0.01%
1,207
-243
-17% -$5K
AMPH icon
456
Amphastar Pharmaceuticals
AMPH
$899M
$26.6K ﹤0.01%
1,000
-230
-19% -$5.94K
TRML
457
DELISTED
Tourmaline Bio
TRML
$26.5K ﹤0.01%
555
-101
-15% -$2.8K
CVAC
458
DELISTED
CureVac
CVAC
$26.1K ﹤0.01%
4,844
-900
-16% -$4.87K
ELVN icon
459
Enliven Therapeutics
ELVN
$3.85B
$26.1K ﹤0.01%
1,274
+23
+2% +$464
AMLX icon
460
Amylyx Pharmaceuticals
AMLX
$2.31B
$26.1K ﹤0.01%
1,918
+218
+13% +$2.05K
GRFS
461
Grifois
GRFS
$5.58B
$25.9K ﹤0.01%
2,605
-518
-17% -$5.18K
ORIC icon
462
Oric Pharmaceuticals
ORIC
$1.2B
$25.1K ﹤0.01%
2,090
+283
+16% +$2.98K
WVE icon
463
Wave Life Sciences
WVE
$1.13B
$25.1K ﹤0.01%
3,424
-481
-12% -$3.89K
DVAX
464
DELISTED
Dynavax Technologies
DVAX
$25.1K ﹤0.01%
2,523
-843
-25% -$8.77K
ELME
465
Elme Communities
ELME
$144M
$25K ﹤0.01%
1,480
-73
-5% -$1.21K
PCRX icon
466
Pacira BioSciences
PCRX
$1.06B
$24.9K ﹤0.01%
967
-215
-18% -$5.28K
IIPR icon
467
Innovative Industrial Properties
IIPR
$1.76B
$24.8K ﹤0.01%
462
-38
-8% -$2.07K
INVA icon
468
Innoviva
INVA
$1.57B
$24.7K ﹤0.01%
1,356
-246
-15% -$4.8K
NTST
469
NETSTREIT Corp
NTST
$2.1B
$24.5K ﹤0.01%
1,354
-87
-6% -$1.57K
PRAX icon
470
Praxis Precision Medicines
PRAX
$8.58B
$24K ﹤0.01%
453
-24
-5% -$1.16K
TRVI icon
471
Trevi Therapeutics
TRVI
$2.61B
$24K ﹤0.01%
2,620
+652
+33% +$4.89K
COLL icon
472
Collegium Pharmaceutical
COLL
$1.17B
$23.7K ﹤0.01%
678
-148
-18% -$5.14K
GTY
473
Getty Realty Corp
GTY
$2.12B
$23.6K ﹤0.01%
880
-42
-5% -$1.17K
RAPP
474
Rapport Therapeutics
RAPP
$2.05B
$23.4K ﹤0.01%
789
-147
-16% -$2.62K
SILA
475
DELISTED
Sila Realty Trust
SILA
$23.1K ﹤0.01%
920
-74
-7% -$1.84K
17 18
19
20 21

Similar funds

CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
BP
BC Partners New York $5.96B AUM 15.21% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $5.94B AUM 18.44% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
AL
Appaloosa LP Short Hills, New Jersey $5.93B AUM 44.55% 1-Year Est. Return
CGPCS
Capital Group Private Client Services Los Angeles, California $5.93B AUM 27.73% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

GF Fund Management's Q3 2025 Portfolio in Review

As of Q3 2025, GF Fund Management held 691 positions worth $5.51B, up 11% from $4.97B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

GF Fund Management's Q3 2025 filing shows 31 new, 112 increased, 426 reduced and 60 closed positions. Its largest new stake was Bloom Energy: 648,856 shares worth $54.9M. The largest sale was British American Tobacco, an estimated $36.2M.

By sector, the portfolio is most concentrated in Technology at 49% of assets, up from 46% a quarter earlier, followed by Communication Services and Consumer Discretionary.

  • GF Fund Management's largest Q3 2025 buy was Bloom Energy: 648,856 shares worth $54.9M.
  • GF Fund Management added most to Lumentum in Q3 2025, an estimated $33.3M increase.
  • GF Fund Management's biggest Q3 2025 reduction was British American Tobacco, cutting an estimated $36.2M.
  • GF Fund Management fully exited Yum China in Q3 2025, selling an estimated $14.8M.
  • GF Fund Management's ten largest holdings make up 46% of its $5.51B portfolio in Q3 2025.
  • GF Fund Management opened 31 new positions and closed 60 in Q3 2025.
  • GF Fund Management's portfolio value rose 11% quarter-over-quarter to $5.51B.

Based on GF Fund Management's 13F filing for Q3 2025, filed 7 Nov 2025.